Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARWR | AMGN | BMY | GILD | VRTX |
| Company | Arrowhead Pharma | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 19.50 | 264.00 | 57.55 | 93.40 | 406.30 |
| High | 19.95 | 264.00 | 57.55 | 93.40 | 406.30 |
| Low | 19.35 | 264.00 | 57.55 | 93.40 | 406.30 |
| Last | 19.75 | 264.00 | 57.55 | 93.40 | 406.30 |
| Change | +0.30 | unch | -0.03 | unch | +1.03 |
| % Change | +1.54% | unch | -0.05% | unch | +0.25% |
| Volume | 1,399,200 | 320,885 | 1,051 | 794 | 1,291 |
| 20-Day Average Volume | 2,274,615 | 4,940,709 | 11,208,072 | 7,067,905 | 1,759,315 |
| Previous Close | 19.45 | 264.00 | 57.58 | 93.40 | 405.27 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 22.55 | 271.99 | 57.86 | 92.28 | 451.91 |
| 20-Day Raw Stochastic | 11.85% | 35.27% | 49.72% | 77.27% | 28.85% |
| 20-Day Relative Strength | 43.90% | 32.92% | 53.29% | 56.96% | 33.20% |
| Weighted Alpha | -48.54 | -14.82 | +19.91 | +25.07 | -8.47 |
| Today's Opinion | 64% Sell | 88% Sell | 80% Buy | 100% Buy | 72% Sell |
| Previous Opinion | 64% Sell | 88% Sell | 80% Buy | 100% Buy | 72% Sell |
| Last Month's Opinion | 88% Sell | 40% Sell | 100% Buy | 80% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -11.71% since 12/16/24 | -0.73% since 12/17/24 | -0.17% since 12/17/24 | +0.65% since 12/17/24 | -13.41% since 12/17/24 |
| Low | 19.18 on 12/20/24 | 253.30 on 12/19/24 | 56.08 on 12/20/24 | 90.27 on 12/19/24 | 377.85 on 12/19/24 |
| High | 22.45 on 12/17/24 | 269.61 on 12/20/24 | 58.54 on 12/18/24 | 93.52 on 12/23/24 | 471.05 on 12/18/24 |
| 1-Month | |||||
| %Chg | +6.53% since 11/22/24 | -10.37% since 11/22/24 | -2.24% since 11/22/24 | +3.56% since 11/22/24 | -9.91% since 11/22/24 |
| Low | 18.73 on 11/25/24 | 253.30 on 12/19/24 | 55.04 on 12/13/24 | 89.15 on 12/13/24 | 377.85 on 12/19/24 |
| High | 27.34 on 11/29/24 | 297.32 on 11/25/24 | 60.68 on 11/25/24 | 94.65 on 12/11/24 | 476.46 on 12/10/24 |
| 3-Month | |||||
| %Chg | -1.25% since 09/23/24 | -20.22% since 09/24/24 | +12.98% since 09/24/24 | +11.47% since 09/24/24 | -12.24% since 09/24/24 |
| Low | 17.05 on 10/10/24 | 253.30 on 12/19/24 | 49.11 on 09/25/24 | 81.83 on 09/26/24 | 377.85 on 12/19/24 |
| High | 27.34 on 11/29/24 | 329.50 on 09/25/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| 6-Month | |||||
| %Chg | -22.55% since 06/21/24 | -17.02% since 06/24/24 | +36.28% since 06/24/24 | +32.05% since 06/24/24 | -14.45% since 06/24/24 |
| Low | 17.05 on 10/10/24 | 253.30 on 12/19/24 | 39.35 on 07/05/24 | 66.01 on 07/05/24 | 377.85 on 12/19/24 |
| High | 30.41 on 07/16/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,457,571 | 141,908,720 | 116,782,440 | 116,401,248 | 104,368,768 |
| Shares Outstanding, K | 124,434 | 537,533 | 2,028,177 | 1,246,266 | 257,529 |
| Annual Sales | 3,550,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -599,490,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 11,892,000,000 | 7,545,000,000 | 2,771,900,000 |
| Last Quarter Net Income | -170,540,000 | 2,830,000,000 | 1,211,000,000 | 1,253,000,000 | 1,045,400,000 |
| 60-Month Beta | 0.90 | 0.55 | 0.45 | 0.18 | 0.36 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.38 on 11/26/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 | 4.38 on 11/04/24 |
| Latest Earnings Date | 02/04/25 | 02/04/25 | 02/06/25 | 02/11/25 | 02/03/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | 0.770 on 12/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 02/14/25 | 01/03/25 | 12/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.70 | 49.00 | 20.90 | 0.00 |